Aprea Therapeutics, Inc. · NASDAQ:APRE
Henneman John B III received 3,135 Aprea Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 16, 2026 · Filed Jun 17, 2026
On Jun 16, 2026, Henneman John B III (Director) received 3,135 Aprea Therapeutics, Inc. shares as an award, leaving 13,364 shares. Filed Jun 17, 2026 (Form 4).
- Awarded
- 3,135 shares
- Holding after
- 13,364 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | Award | 3,135 | 13,364 | Direct |